Here’s a look at how emergency room experiences affect linkage to care and retention in care among patients with HIV.
Here: an update on progress and challenges in HIV eradication, and a focus on the efforts of the President’s Emergency Plan for AIDS Relief.
Is pre-exposure prophylaxis an effective means of reducing the number of new HIV infections?
Do we, in resource-rich countries, have the will and the resources to spend on HIV or HCV eradication? We have the tools (medications), but the goal of eradicating both infections seems as elusive as ever.
It turns out that where a patient gets a diagnosis of HIV affects how quickly he or she gets treatment for the infection.
Low-cost interventions can improve compliance with HIV therapy, which is directly linked to viral suppression and reduced transmission to partners.
If we had a vaccine that was as effective at reducing HIV infection as circumcision, it would be a recommended vaccine here in the US, argues this pediatrician.
Primary care clinicians take note: here’s a case for routine screening and treatment of early cryptococcal infection, given its prevalence and sequelae in patients with HIV/AIDS.
Younger antiretroviral therapy enrollees differ from older ones in demographic and clinical characteristics and are at higher risk for loss to follow-up. But interventions could reduce mortality and incidence.
Immune reconstitution inflammatory syndrome is seen in some HIV-infected patients soon after initiation of antiretroviral therapy. The syndrome can “unmask” dormant opportunistic infections or aggravate existing infections.